Summary
4.14 0.06(1.47%)10/04/2024
Orasure Technologies Inc. (OSUR)
Orasure Technologies Inc. (OSUR)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| 1.47 | -3.50 | -5.80 | 5.48 | -31.20 | -29.83 | -45.53 | 153.91 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 4.14 | |
| Open | 4.14 | |
| High | 4.16 | |
| Low | 4.07 | |
| Volume | 374,993 | |
| Change | 0.06 | |
| Change % | 1.47 | |
| Avg Volume (20 Days) | 407,902 | |
| Volume/Avg Volume (20 Days) Ratio | 0.92 | |
| 52 Week Range | 3.92 - 8.45 | |
| Price vs 52 Week High | -51.01% | |
| Price vs 52 Week Low | 5.61% | |
| Range | 0.00 | |
| Gap Up/Down | 0.03 | |
Fundamentals | ||
| Market Capitalization (Mln) | 318 | |
| EBIDTA | 35,256,000 | |
| PE Ratio | 6.7500 | |
| PEG Ratio | 2.3000 | |
| WallStreet Target Price | 6.94 | |
| Book Value | 5.7630 | |
| Earnings Per Share | 0.7200 | |
| EPS Estimate Current Quarter | 0.0100 | |
| EPS Estimate Next Quarter | -0.0100 | |
| EPS Estimate Current Year | -0.1300 | |
| EPS Estimate Next Year | -0.2400 | |
| Diluted EPS (TTM) | 0.7200 | |
| Revenues | ||
| Profit Marging | 0.0750 | |
| Operating Marging (TTM) | -0.0619 | |
| Return on asset (TTM) | 0.0306 | |
| Return on equity (TTM) | 0.0557 | |
| Revenue TTM | 304,640,992 | |
| Revenue per share TTM | 4.1420 | |
| Quarterly Revenue Growth (YOY) | -0.6510 | |
| Quarterly Earnings Growth (YOY) | 0.2960 | |
| Gross Profit (TTM) | 147,637,000 | |
| Dividends | ||
| Dividend Share | 0.0000 | |
| Dividend Yield | ||
| Valuations | ||
| Trailing PE | 6.7500 | |
| Forward PE | 0.0000 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 0.9806 | |
| Revenue Enterprise Value | 0.3587 | |
| EBITDA Enterprise Value | 2.2599 | |
| Shares | ||
| Shares Outstanding | 76,510,000 | |
| Shares Float | 67,166,128 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.06 | |
| Insider (%) | 3.79 | |
| Institutions (%) | 99.27 | |
10/04 16:03 EST - gurufocus.com
Neuberger Berman Group LLC Expands Stake in OraSure Technologies Inc
On September 30, 2024, Neuberger Berman Group LLC, a prominent investment firm, made a significant addition to its investment portfolio by acquiring 3,927,692 shares of OraSure Technologies Inc (OSUR, Financial). This transaction, executed at a price of $4.27 per share, marks a notable increase in the firm's holdings in the medical devices sector.
Neuberger Berman Group LLC Expands Stake in OraSure Technologies Inc
On September 30, 2024, Neuberger Berman Group LLC, a prominent investment firm, made a significant addition to its investment portfolio by acquiring 3,927,692 shares of OraSure Technologies Inc (OSUR, Financial). This transaction, executed at a price of $4.27 per share, marks a notable increase in the firm's holdings in the medical devices sector.
09/09 07:05 EST - globenewswire.com
OraSure Technologies Elects Jack Kenny to the Board of Directors
BETHLEHEM, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions today announced the election of Jack Kenny to its Board of Directors, effective September 9, 2024. With the addition of Mr. Kenny, OraSure's Board of Directors currently has seven members.
OraSure Technologies Elects Jack Kenny to the Board of Directors
BETHLEHEM, Pa., Sept. 09, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions today announced the election of Jack Kenny to its Board of Directors, effective September 9, 2024. With the addition of Mr. Kenny, OraSure's Board of Directors currently has seven members.
08/06 21:04 EST - seekingalpha.com
OraSure Technologies Inc (OSUR) Q2 2024 Earnings Call Transcript
OraSure Technologies Inc (NASDAQ:OSUR ) Q2 2024 Results Conference Call August 6, 2024 5:00 PM ET Company Participants Jason Plagman - Vice President-Investor Relations Carrie Eglinton Manner - President and Chief Executive Officer Ken McGrath - Chief Financial Officer Conference Call Participants Casey Woodring - JPMorgan Andrew Cooper - Raymond Jones Operator Good day, and thank you for standing by. Welcome to the OraSure Technologies Incorporated 2024 Second Quarter Earnings Conference Call.
OraSure Technologies Inc (OSUR) Q2 2024 Earnings Call Transcript
OraSure Technologies Inc (NASDAQ:OSUR ) Q2 2024 Results Conference Call August 6, 2024 5:00 PM ET Company Participants Jason Plagman - Vice President-Investor Relations Carrie Eglinton Manner - President and Chief Executive Officer Ken McGrath - Chief Financial Officer Conference Call Participants Casey Woodring - JPMorgan Andrew Cooper - Raymond Jones Operator Good day, and thank you for standing by. Welcome to the OraSure Technologies Incorporated 2024 Second Quarter Earnings Conference Call.
08/06 19:27 EST - zacks.com
OraSure Technologies (OSUR) Tops Q2 Earnings and Revenue Estimates
OraSure Technologies (OSUR) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to loss of $0.07 per share a year ago.
OraSure Technologies (OSUR) Tops Q2 Earnings and Revenue Estimates
OraSure Technologies (OSUR) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to loss of $0.07 per share a year ago.
07/22 16:05 EST - globenewswire.com
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
BETHLEHEM, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2024 financial results and certain business developments for 5 p.m. ET on August 6, 2024.
OraSure to Announce Second Quarter 2024 Financial Results and Host Earnings Call on August 6th
BETHLEHEM, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering second quarter 2024 financial results and certain business developments for 5 p.m. ET on August 6, 2024.
06/27 07:05 EST - globenewswire.com
OraSure Technologies Supports National HIV Testing Day
BETHLEHEM, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions today announced its support of HIV testing initiatives taking place across the nation in recognition of National HIV Testing Day, held each year on June 27th. These testing initiatives will help encourage thousands of people across the U.S. to get tested for HIV.
OraSure Technologies Supports National HIV Testing Day
BETHLEHEM, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests and sample management solutions today announced its support of HIV testing initiatives taking place across the nation in recognition of National HIV Testing Day, held each year on June 27th. These testing initiatives will help encourage thousands of people across the U.S. to get tested for HIV.
05/08 19:20 EST - zacks.com
OraSure Technologies (OSUR) Q1 Earnings Meet Estimates
OraSure Technologies (OSUR) came out with quarterly earnings of $0.04 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.37 per share a year ago.
OraSure Technologies (OSUR) Q1 Earnings Meet Estimates
OraSure Technologies (OSUR) came out with quarterly earnings of $0.04 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.37 per share a year ago.
04/22 08:00 EST - globenewswire.com
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
BETHLEHEM, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2024 financial results and certain business developments for 4:45 p.m. ET on Wednesday, May 8, 2024.
OraSure to Announce First Quarter 2024 Financial Results and Host Earnings Call on May 8th
BETHLEHEM, Pa., April 22, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2024 financial results and certain business developments for 4:45 p.m. ET on Wednesday, May 8, 2024.
04/18 11:30 EST - investorplace.com
Wall Street Favorites: 3 Under-$10 Stocks With Strong Buy Ratings for April 2024
Penny stocks are those that trade under $5. We'll call stocks that trade between $5 and $10 near-penny stocks.
Wall Street Favorites: 3 Under-$10 Stocks With Strong Buy Ratings for April 2024
Penny stocks are those that trade under $5. We'll call stocks that trade between $5 and $10 near-penny stocks.
03/21 08:31 EST - businesswire.com
NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board
SPRINGDALE, Ark.--(BUSINESS WIRE)--NOWDiagnostics (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostics tests and first-in-class technology and platforms, today announced the appointment of Dr. Stephen S. Tang, Ph.D., MBA, as the chairman of the company's board of directors. Dr. Tang is a longtime veteran of the medical diagnostic industry. He led OraSure Technologies, Inc. (NASDAQ: OSUR), a pioneer and global leader in rapid at-home tests for HIV and COVID-19, for.
NOWDiagnostics Welcomes Dr. Stephen S. Tang as Chairman of the Board
SPRINGDALE, Ark.--(BUSINESS WIRE)--NOWDiagnostics (NOWDx), a developer of over-the-counter (OTC) and point-of-care (POC) diagnostics tests and first-in-class technology and platforms, today announced the appointment of Dr. Stephen S. Tang, Ph.D., MBA, as the chairman of the company's board of directors. Dr. Tang is a longtime veteran of the medical diagnostic industry. He led OraSure Technologies, Inc. (NASDAQ: OSUR), a pioneer and global leader in rapid at-home tests for HIV and COVID-19, for.
02/27 22:16 EST - seekingalpha.com
OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript
OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript
OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript
OraSure Technologies, Inc. (OSUR) Q4 2023 Earnings Call Transcript
02/27 16:05 EST - globenewswire.com
OraSure Reports Q4 ‘23 Revenue of $75.9 Million
Q4 GAAP EPS of $0.27 ; Q4 Non-GAAP EPS of $0.22 Grew cash balance to $290.4 million as of December 31, 2023 E nters U.S. Syphilis testing market via strategic distribution agreement with Diagnostics Direct BETHLEHEM, Pa., Feb. 27, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services, today announced its financial results for the three months ended December 31, 2023.
OraSure Reports Q4 ‘23 Revenue of $75.9 Million
Q4 GAAP EPS of $0.27 ; Q4 Non-GAAP EPS of $0.22 Grew cash balance to $290.4 million as of December 31, 2023 E nters U.S. Syphilis testing market via strategic distribution agreement with Diagnostics Direct BETHLEHEM, Pa., Feb. 27, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, sample management solutions, and microbiome laboratory and analytical services, today announced its financial results for the three months ended December 31, 2023.
02/13 16:05 EST - globenewswire.com
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
BETHLEHEM, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2023 financial results and certain business developments for 5 p.m. ET on Tuesday, Feb. 27, 2024.
OraSure to Announce Fourth Quarter 2023 Financial Results and Host Earnings Call on February 27th
BETHLEHEM, Pa., Feb. 13, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2023 financial results and certain business developments for 5 p.m. ET on Tuesday, Feb. 27, 2024.
02/01 18:42 EST - investorplace.com
3 Strong Buy Stocks Under $10: January 2024
Investors seeking strong buy stocks under $10 offering a potential future of large returns can be difficult. Inexpensive companies tend to have a small market cap and are typically riskier investments compared to stocks that trade for a higher market cap.
3 Strong Buy Stocks Under $10: January 2024
Investors seeking strong buy stocks under $10 offering a potential future of large returns can be difficult. Inexpensive companies tend to have a small market cap and are typically riskier investments compared to stocks that trade for a higher market cap.
01/18 08:41 EST - zacks.com
Buy These 4 Low-Beta Stocks to Counter Market Volatility
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Otter Tail (OTTR), Regeneron (REGN), OraSure (OSUR) and BioMarin Pharmaceutical (BMRN) are well-poised to gain.
Buy These 4 Low-Beta Stocks to Counter Market Volatility
It is imperative to build a portfolio of low-beta stocks to sail through a volatile market. Otter Tail (OTTR), Regeneron (REGN), OraSure (OSUR) and BioMarin Pharmaceutical (BMRN) are well-poised to gain.
01/04 07:05 EST - globenewswire.com
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company
The relationship expands OraSure's innovation pipeline with access to a broad portfolio of key Sapphiros products in development.
OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests in Sapphiros, a Next-Generation Consumer Diagnostics Company
The relationship expands OraSure's innovation pipeline with access to a broad portfolio of key Sapphiros products in development.
11/27 11:17 EST - zacks.com
After Golden Cross, OraSure Technologies (OSUR)'s Technical Outlook is Bright
After reaching an important support level, OraSure Technologies, Inc. (OSUR) could be a good stock pick from a technical perspective. OSUR recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
After Golden Cross, OraSure Technologies (OSUR)'s Technical Outlook is Bright
After reaching an important support level, OraSure Technologies, Inc. (OSUR) could be a good stock pick from a technical perspective. OSUR recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
11/13 16:15 EST - globenewswire.com
OraSure to Participate in Upcoming Investor Conferences
BETHLEHEM, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced the company is scheduled to participate in the following investor conferences:
OraSure to Participate in Upcoming Investor Conferences
BETHLEHEM, Pa., Nov. 13, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced the company is scheduled to participate in the following investor conferences:
11/09 11:12 EST - investorplace.com
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
If you're a fan of the hit TV show Shark Tank, you've probably come across the intriguing term “unicorn” companies. Indeed, these fantastical entities are not only confined to the realm of imagination.
7 Healthcare Stocks That Are Poised to Become the Next Unicorns
If you're a fan of the hit TV show Shark Tank, you've probably come across the intriguing term “unicorn” companies. Indeed, these fantastical entities are not only confined to the realm of imagination.
11/07 20:17 EST - zacks.com
OraSure Technologies (OSUR) Tops Q3 Earnings and Revenue Estimates
OraSure Technologies (OSUR) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.07 per share a year ago.
OraSure Technologies (OSUR) Tops Q3 Earnings and Revenue Estimates
OraSure Technologies (OSUR) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to earnings of $0.07 per share a year ago.